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PValvular Heart Disease
ardiopulmonary Exercise
esting Determination of
unctional Capacity in Mitral Regurgitation
hysiologic and Outcome Implications
avid Messika-Zeitoun, MD,* Bruce D. Johnson, PHD,* Vuyisile Nkomo, MD,*
ean-François Avierinos, MD,* Thomas G. Allison, PHD,* Christopher Scott, MS,†
. Jamil Tajik, MD,* Maurice Enriquez-Sarano, MD*
ochester, Minnesota
OBJECTIVES This study was designed to evaluate prevalence, determinants, and clinical outcome
implications of reduced functional capacity (FC) in patients with organic mitral regurgitation
(MR).
BACKGROUND Evaluation of FC by exercise testing is rarely performed in MR because little is known about
the clinical determinants and outcome implications of FC.
METHODS Cardiopulmonary exercise testing (CPET) was prospectively performed in 134 asymptomatic
patients with organic MR to assess FC (peak oxygen consumption [VO2]) simultaneously to
Doppler-echocardiographic quantitation of MR (effective regurgitant orifice [ERO]) and left
ventricular (LV) systolic and diastolic function.
RESULTS Peak VO2 was 26  6 ml/kg/min (96  16% of age-predicted), but varied widely (57% to
145% of predicted) and was markedly reduced (84% of predicted) in 19% of patients.
Although ERO of MR was univariately associated with reduced FC (26 vs. 9% with ERO
40 vs. 40 mm2), independent determinants of reduced FC were LV diastolic function
(higher E/E= ratio, p 0.006), atrial fibrillation (p 0.01), and lower forward stroke volume
(p  0.03). Clinical events (death, heart failure, new atrial fibrillation) and clinical events or
surgery were more frequent with than without reduced FC (3 years, 36  14% vs. 13  4%,
p 0.02; and 66 11% vs. 29 5%, p 0.001, respectively), even adjusting (risk ratios 1.80
and 1.54 respectively, both p  0.03) for age and ERO.
CONCLUSIONS In asymptomatic organic MR, FC quantitatively assessed by CPET is unexpectedly markedly
reduced in one out of every four to five patients. Reduced FC is independently determined by
consequences rather than severity of MR and predicts increased subsequent clinical events.
Therefore, CPET frequently reveals functional limitations not detected clinically and is an
important tool in managing patients with organic MR. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.02.0432521–7) © 2006 by the American College of Cardiology Foundation
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Mhe management of patients with mitral regurgitation (MR) is
ased, in great part, on functional limitations occurring with
ctivity (1). In asymptomatic patients, no limitation is clinically
etected, but this subjective assessment does not account for
he physical activity level of patients who are often sedentary.
ecent outcome studies reported notable risks incurred by
ubsets of asymptomatic patients with MR (2,3), and guide-
ines underscore the importance of “a well established estima-
ion of exercise tolerance” and recommend exercise testing to
bjectively assess exercise tolerance (1). However, the incre-
ental information provided by exercise testing in asymptom-
tic patients with organic MR is uncertain, and this test is
arely performed (4). Few reports objectively define functional
From the *Division of Cardiovascular Diseases and Internal Medicine and the
Section of Biostatistics, Mayo College of Medicine, Rochester, Minnesota. Dr.
essika-Zeitoun was supported by a grant from the Federation Française de
ardiologie. The study was supported in part by grants HL 64928 and M01-
R00585 of the National Institutes of Health.q
Manuscript received August 24, 2005; revised manuscript received January 27,
006, accepted February 7, 2006.apacity (FC) in MR; they involved limited numbers of
atients (5–7) and did not analyze FC’s link to clinical
utcome.
Defining FC determinants in organic MR is a vexing
roblem. Although some patients with severe MR complain
f no functional limitation, others with similar MR develop
evere functional limitations (2,3,8). Increasing evidence,
articularly based on Doppler tissue imaging (9), links
iastolic function to exercise capacity (10,11), but such
vidence is lacking in MR. Cardiopulmonary exercise test-
ng (CPET) with determination of gas exchange provides
uantitative, objective, and noninvasive evaluation of FC
nd allows risk stratification in patients with congestive
eart failure (12). Cardiopulmonary exercise testing ac-
ounts for the expected decrease in FC capacity with age
nd gender (13).
One of our aims was to prospectively and objectively
ssess FC by CPET in asymptomatic patients with organic
R. We also used a comprehensive echocardiographic
uantification of MR severity, left ventricular (LV) and left
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Functional Capacity in MR June 20, 2006:2521–7trial (LA) remodeling, and LV systolic and diastolic
unction, to evaluate FC determinants. Our hypothesis was
hat FC reduction is frequent, is independently determined
y diastolic LV dysfunction after adjusting for MR severity,
nd is a marker for subsequent clinical events.
ETHODS
tudy population. Between 1998 and 2004, asymptomatic
atients with organic MR were prospectively and consecu-
ively evaluated using quantitative echocardiography and
PET. Inclusion criteria were patients: 1) with pure,
solated MR and regurgitant volume (RVol) 30 ml/beat)
14) quantified by at least two methods; 2) with quantitative
ssessment of cardiac remodeling and LV systolic and
iastolic function; 3) who performed a maximal exercise
est, i.e., achieving their heart rate goal (85% of the
ge-predicted peak heart rate) or stopped because of symp-
oms of dyspnea, exhaustion, or hypotension; and 4) in
hom echocardiography and CPET were performed during
he same episode of care without intervening clinical
hange. Exclusion criteria were: 1) age90 years; 2) history
f congestive heart failure; 3) rheumatic mitral stenosis of
ny degree; 4) moderate or more severe lung disease;
) exercise limited by angina; and 6) exercise testing stopped
ecause of ischemia or severe arrhythmia.
chocardiographic measurements. QUANTIFICATION OF
R. Degree of MR was quantified by at least two of the
ollowing three methods, which were systematically per-
ormed and were averaged to calculate RVol and effective
egurgitant orifice (ERO): quantitative Doppler based on
itral and aortic stroke volumes, quantitative two-
imensional echocardiography based on LV stroke volume
easurement, and the proximal isovelocity surface area
ethod based on analysis of proximal flow convergence
14). Severe MR was defined by RVol60 ml/beat or ERO
40 mm2 (14).
VALUATION OF DIASTOLIC FUNCTION. Mitral inflow was
ecorded at mitral leaflet tips, and velocities of early diastolic
ow (E-wave), late diastolic flow (A-wave), E-wave decel-
ration time, and E/A ratio were measured. With Doppler
Abbreviations and Acronyms
CI  confidence interval
CPET  cardiopulmonary exercise testing
ERO  effective regurgitant orifice
FC  functional capacity
LA  left atrium
MR  mitral regurgitation
RER  respiratory exchange ratio
RR  risk ratio
RVol  regurgitant volume
VCO2  carbon dioxide production
VE  minute ventilation
VO2  oxygen consumptionissue imaging, septal early diastolic tissue velocity (E=) was pecorded, and the E/E= ratio was calculated with at least
hree measurements averaged.
VANDLAFUNCTIONANDREMODELINGASSESSMENT. Mea-
urements of LV size (LV end-diastolic and -systolic
olume index), ejection fraction, and LV mass were per-
ormed as recommended by the American Society of Echo-
ardiography (15). End-systolic wall stress calculation used
stimated end-systolic pressure and echocardiographic LV
eometry and wall thickness. Left atrial volume was mea-
ured by area-length method (16).
ardiopulmonary exercise testing. Symptom-limited
readmill exercise testing with respiratory gas exchange
nalysis used modified Bruce protocol (2-min workloads, 2
/min increments in work).
Electrocardiograms were continuously monitored and
lood pressure was assessed the last 30 s of each 2-min
orkload. Patients were encouraged to exercise to exhaus-
ion. Exercise duration was expressed in minutes and in
ercent of age- and gender-predicted value (13). Breath-by-
reath minute ventilation (VE), carbon dioxide production
VCO2), their ratio (VE/VCO2), and oxygen consumption
VO2) were measured using a Medical Graphics metabolic
art (St. Paul, Minnesota). Calibration used gravimetric
uality gases before each test and physiologic calibration for
eekly quality control. Peak VO2 was the highest averaged
0-s VO2 during exercise and was expressed as absolute
eak-VO2 or normalized peak VO2 (percent of age, gender,
nd weight predicted) (13). Normalized peak-VO2 was
alculated offline, with FC considered markedly reduced
ith peak VO2 84% of predicted (17) and was not
vailable to patients’ independent physicians, who con-
ucted clinical management. The O2-pulse, an estimate of
troke volume, was calculated as VO2/heart rate. Quality of
xercise effort was assessed by respiratory exchange ratio
RER) (17).
tatistical analysis. Data are presented as mean  SD or
ercent. Comparisons between groups used analysis of
ariance (with Tukey-HSD test) or chi-square test as
ppropriate. Correlations to peak VO2 were assessed using
inear regression for continuous variables and Spearman
egression for categorical variables. Stepwise multiple linear
egression analysis was used to identify determinants of
bsolute and normalized peak VO2. Clinical, hemodynamic,
ardiac remodeling, MR severity, diastolic function, and
entilatory variables with the highest correlation with peak
O2 were entered stepwise in the model. Outcome was
nalyzed using three end points: clinical events (death, heart
ailure or new severe symptoms, new atrial arrhythmia)
nder conservative management, indication for surgery, and
he combined end point of clinical events or surgery. Event
ates were estimated using the Kaplan-Meier method and
ompared between groups using the log-rank test. The
ssociation of FC with the end points was determined using
he Cox proportional hazards method with and without
djustment to other determinants of outcome. A value of
 0.05 was significant.
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aseline characteristics. We prospectively enrolled 134
atients (63  14 years, 63% men) with MR in whom
itral valve prolapse (with or without flail) was the main
tiology (93%). Six patients (5%) were in atrial fibrillation.
uantitation of MR showed excellent correlation between
ethods (all r  0.90), which were averaged for simplifi-
ation. Mitral regurgitation was often severe (77 of 132
atients, 57%), with a wide range (RVol: 68  24 ml/beat;
ange 30 to 146 ml/beat; ERO: 35  14 mm2, range 14 to
3 mm2). Ejection fraction was 73  6% and was 55% in
ll patients. Mean E/E= ratio was 12  5 and 15 (9) in
9%. Main clinical and echocardiographic characteristics are
resented in Table 1 (left column).
unctional capacity in MR. Interval between CPET and
chocardiography was 2  3 days. Exercise testing was termi-
ated because of symptoms in 132 patients and hypotension in
patients. Mean RER was 1.12  0.08, confirming appro-
riate effort in most patients. Exercise testing characteristics are
ummarized in Table 2.
OMPREHENSIVE ANALYSIS OF THE FUNCTIONAL CAPAC-
TY. Absolute peak VO2 was 26  6 ml/kg/min with wide
ange (15.6 to 49.0 ml/kg/min) and expected negative
orrelation with age (r  0.54, p  0.0001), female
ender (r  0.29, p  0.002), and body mass index (r 
0.29, p  0.002). Normalized peak VO2 was close to
ormal (96  16% of predicted) and showed no correlation
able 1. Baseline Resting Characteristic of the Population Overa
Category Variable Name, U
Overall
(n  134)
N
(n
linical Age, yrs 63  14 64
Male gender 85 (63) 70
Body mass index, kg/m2 26  4 26
Beta-blocker therapy 31 (23) 27
Atrial fibrillation 6 (5) 4
emodynamic HR, beats/min 66  10 64
Forward stroke volume, ml 79  16 81
Cardiac index, l/min/m2 2.7  0.5 2.7
S-PAP, mm Hg 32  9 32
ardiac remodeling EDVI, ml/m2 108  20 109
ESVI, ml/m2 29  10 30
LV mass/volume, g/ml 1.1  0.2 1.1
LVEF, % 73  6 73
ESWS/ESVI, g/cm2
per ml/m2
5.3  1.4 5.3
LA index, ml/m2 68  26 68
R severity RVol, ml/beat 68  24 68
ERO, mm2 35  14 34
iastolic function E/A ratio 1.4  0.5 1.4
Deceleration time, ms 213  40 215
E/E= ratio 12  5 12
ata presented are number of patients (percent) or mean  SD. *p  0.05 vs. patien
unctional limitations.
DBP  diastolic blood pressure; EDVI  end-diastolic volume index; EF  ej
SWS  end-systolic wall stress; FC  functional capacity; HR  heart rate; LA 
ulmonary artery pressure; VO2  oxygen consumption.o age, gender, and body mass index (all p  0.05), aonfirming appropriate adjustment. Nevertheless, normal-
zed peak VO2 varied widely, from 57% to 145% of pre-
icted, even in patients with severe MR (57% to 145%).
Functional capacity was markedly reduced (84% of ex-
ected) in 26 patients (19%), was equally distributed in patients
ith and without RVol60 ml/beat (both 19%), and was 26%
ersus 17% in patients with and without ERO40 mm2 (p
.23). There were eight patients with a potentially extraneous
omponent to FC limitations (orthopedic, uncomfortable on
he treadmill, obesity), and 18 had no other cause than MR
MR-related reduced FC). Exercise effort measured by peak-
ER was similarly high with normal FC and with MR-related
educed FC (1.12 0.08 vs. 1.14 0.07, p 0.32), whereas
t was lower with extraneous component to FC limitations
1.05  0.08, p  0.02).
Among the 126 asymptomatic patients with no extrane-
us component to FC limitations, markedly reduced FC
as noted in 18 patients (14%) overall, in 18% versus 8% of
atients with and without RVol 60 ml/beat (p  0.09),
nd in 26% versus 9% of patients with and without ERO
40 mm2 (p  0.02). Examples of CPET with exercise in
patient with normal FC and a patient with MR-related
educed FC are shown in Figure 1 without and with plateau
n VO2 and O2 pulse characteristic of cardiac limitations.
EAK VO2 VERSUS EXERCISE DURATION. The correlation
etween peak-VO2 and exercise duration was good (r 
.80, p  0.0001), but exercise duration was dependent on
According to the Functional Capacity
l
8)
Reduced FC Correlation to
Percent of
Predicted VO2†
MR-
Related
(n  18)
Extraneous
Component
(n  8)
p Value
for the
3 Groups r Value p Value
3 57  13 60  22 0.15 0.16 0.08
12 (67) 3 (38) 0.29 0.09 0.30
26  4 26  8 0.90 0.09 0.34
3 (18) 1 (13) 0.59 0.02 0.84
2 (11) 0 0.30 0.24 0.0007
74  10* 69  7 0.0002 0.29 0.0009
6 75  18 68  10 0.05 0.21 0.02
.5 2.8  0.4 2.6  0.4 0.40 0.13 0.14
36  16* 31  9 0.14 0.22 0.02
9 112  21 91  17* 0.03 0.12 0.19
0 31  10 25  9 0.34 0.01 0.89
.2 1.0  0.2 1.1  0.2 0.30 0.13 0.16
73  5 74  6 0.95 0.05 0.61
.5 5.0  1.2 5.8  1.7 0.53 0.02 0.79
3 80  40 52  24 0.03 0.08 0.37
4 79  23 49  16 0.01 0.11 0.21
2 46  16* 25  8 0.0002 0.23 0.01
.5 1.5  0.4 1.2  0.3 0.28 0.06 0.50
8 201  46 208  25 0.37 0.22 0.02
14  9* 11  4 0.09 0.30 0.0001
normal functional capacity; †applies to patients without extraneous contribution to
fraction; ERO  effective regurgitant orifice; ESVI  end-systolic volume index;
rium; RVol  regurgitant volume; SBP  systolic blood pressure; S-PAP  systolicll and
orma
FC
 10
 1
(65)
 4
(25)
(4)
 9
 1
 0
 7
 1
 1
 0
 6
 1
 2
 2
 1
 0
 3
 4
ts with
ectionge (r  0.50, p  0.0001) and gender (r  0.29, p 
0
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Functional Capacity in MR June 20, 2006:2521–7.001), and no threshold of exercise duration predicted FC
eduction with both sensitivity and specificity 80%. Sen-
itivity, specificity, and positive and negative predictive
alues of exercise duration 9.4 min were modest (72%,
4%, 93%, and 26%, respectively).
eterminants of the FC. Comparisons between patients
ith and without markedly reduced FC for baseline charac-
eristics and correlations to normalized peak VO2 are presented
n the mid and right panels of Tables 1 and 2. Exercise effort
ssessed by RER, peak heart rate, and frequency of patients
ho reached their heart rate goal were not different between
atients with reduced and normal FC (all p  0.05). Lower
ouble-product with reduced FC was related to lower peak
ystolic blood pressure. In MR-related markedly reduced FC,
2-pulse (estimate of stroke volume) was lower at peak and
ncreased less with exercise, reflecting an inability to increase
orward stroke volume with exercise. In MR-related reduced
C, higher pulmonary pressure, LA volume, and ERO link
educed FC and MR. Reduced FC is univariately associated
ith atrial fibrillation, higher resting heart rate, lower resting
orward stroke volume, and higher E/E= ratio (strongest
ssociation with diastolic function parameters). In contrast, no
arameter of LV systolic function or ventilatory efficiency
howed associations with peak VO2.
Using multiple linear regression, independent predictors of
ower absolute peak VO2, adjusting for age, gender, and body
ass index (all p  0.0001), were higher E/E= ratio (LV
iastolic dysfunction, p  0.0003), low forward aortic stroke
olume (p  0.001), and atrial fibrillation (p  0.005). These
eterminants predicted most peak VO2 variability (R2 0.67)
nd were not affected by excluding patients in atrial fibrillation.
able 2. Exercise Characteristic of the Overall Population and in
o Peak VO2
Category Variable Name
Overall
(n  134)
Normal F
(n  10
entilatory VE/VCO2 slope 30  4 30  4
efore exercise SBP, mm Hg 128  17 129  1
DBP, mm Hg 74  11 73  9
eak exercise Peak HR, beats/min 150  22 151  2
Peak HR 85%
predicted
115 (86) 95 (88)
Peak SBP, mm Hg 183  24 185  2
Peak DBP, mm Hg 77  13 78  1
Double product 27,426  5,203 27,930  4
Exercise duration, min 10  3 10  3
Peak O2 pulse, ml/beat 13  4 14  4
O2 pulse increase,
ml/beat
9  3 9  3
Absolute peak VO2,
ml/kg/min
26  6 27  6
Percent of predicted
peak VO2
96  16 102  1
ata presented are number of patients (percent) or mean  SD. *p  0.05 vs. patie
imitations.
HR heart rate; LA left atrium; RVol regurgitant volume; SBP systolic bl
onsumption.he same determinants (E/E= ratio, p 0.006; forward stroke 1olume, p  0.03; atrial fibrillation, p  0.01) independently
etermined normalized peak VO2. After adjustment for these
ariables, ERO showed no independent association with re-
uced FC. Including the eight patients with potential extra-
eous component to FC limitations, FC determinants were
nchanged. Abnormal LV diastolic function (E/E= 15 or
15 [9]), low stroke volume ( or lower quartile), and atrial
brillation exerted a cumulative effect on FC as patients with
arkedly reduced FC represented 11%, 15%, and 40% of those
ith 0, 1, and 2 abnormalities, respectively (p  0.05).
linical outcome. During follow-up under conservative
anagement of 288 patient-years (mean 2.2  1.3 years),
linical events occurred in 20 patients (3 deaths, 15 conges-
ive heart failure or occurrence of severe symptoms, and 2
trial arrhythmias), corresponding to 4-year incidence of
6  7% by Kaplan-Meier method. Ultimately, 42 patients
nderwent surgery for mitral regurgitation (12 for new
ymptoms and 30 based on patient and physician prefer-
nce, supported by severity of MR, LV and LA remodeling,
nd progression), corresponding to four-year incidence of
3  7%. Clinical events or mitral surgery occurred in a
otal of 50 patients, or 53  8% at 4 years.
Patients with reduced FC displayed a higher three-year rate
f clinical events than those with normal FC (36 14% vs. 13
4%, p  0.02), even excluding patients with potential
xtraneous component to FC limitations (p 0.049). Reduced
C was univariately associated with higher risk of clinical
vents (risk ratio [RR] 1.72 [95% confidence interval (CI) 1.01
o 2.76], p 0.045) and remained so with almost unchanged
R after adjustment for age and ERO (RR 1.80 [95% CI 1.06
o 2.92], p  0.03) and additionally for gender and EF (RR
groups According to the Functional Capacity with Correlations
Reduced FC
p Value
for the
3 Groups
Correlation to
Percent of
Predicted VO2†MR-Related
(n  18)
Extraneous
(n  8) r Value p Value
30  5 30  5 0.97 0.14 0.13
124  19 123  21 0.32 0.03 0.79
78  19 70  14 0.16 0.16 0.09
147  30 150  30 0.76 0.10 0.27
13 (72) 7 (88) 0.21 0.16 0.08
171  24* 174  25 0.04 0.08 0.37
71  13 83  10 0.06 0.21 0.02
25,150  6,458* 25,736  5,075 0.07 0.12 0.18
9  3* 7  3* 0.0005 0.36 0.0001
12  4* 10  2* 0.002 0.26 0.004
7  3* 6  1* 0.001 0.29 0.001
22  5* 20  4* 0.0001 — —
74  8* 78  4* 0.0001 — —
th normal functional capacity; †excluding the 8 patients with extraneous functional
essure; VCO2 carbon dioxide production; VEminute ventilation; VO2 oxygenSub
C
8)
6
0
4
2
,899
2
nts wi.78 [95% CI 1.04 to 2.87], p  0.035). Longer exercise time
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June 20, 2006:2521–7 Functional Capacity in MRas univariately associated with lower risk of clinical events
RR 0.85 [95% CI 0.73 to 0.98], p 0.03) but lost significance
igure 1. Example of exercise progression in two patients of similar age (57
nd 59 years), degree of regurgitation (regurgitant volume of 77 and 78
l/beat), and peak heart rate with exercise (156 vs. 153 beats/min). (A) Plot of
eak-VO2 versus exercise time. The first patient (closed circles) displays
ormal functional capacity (normal peak VO2, 114% of predicted), whereas the
econd (open circles) has reduced functional capacity (reduced peak VO2, 68%
f predicted), with plateau of O2 consumption toward the end of exercise.
B) Plot of respiratory exchange ratio (RER) versus exercise time in these two
atients. Note that despite the marked differences in exercise capacity, both
atients provide a maximum exercise effort with RER increasing above 1.1
1.12 and 1.26 at peak exercise, respectively). (C) Plot of O2 pulse versus
xercise time. The first patient with normal peak VO2 (closed circles) reaches
higher peak O2 pulse (18.3) versus that reached by the patient with reduced
eak VO2 (open circles, 10.8) reflecting higher stroke volume with exercise.
lso note the plateau in VO2 and O2 pulse in the patient with mitral
egurgitation-related reduced peak VO2.fter adjustment for age and ERO (p  0.11).
r
rPatients with reduced FC displayed a higher three-year
ncidence of mitral surgery than those with normal FC
53  12% vs. 29 5%, p 0.03), even when patients with
otential extraneous component to FC limitations were
xcluded from the comparison (p  0.005). Patients with
educed FC also displayed a higher three-year rate of
ombined end point (clinical event or surgery) than those
ith normal FC (66  11% vs. 29  5%, p  0.001)
Fig. 2), even excluding patients with potential extraneous
omponent to FC limitations (p 0.005). Reduced FC was
nivariately associated with higher risk of combined end
oint (RR 1.62 [1.18 to 2.19], p  0.004) and remained so
ith almost unchanged RR after adjustment for age and
RO (RR 1.54 [1.10 to 2.09], p  0.01), even after
dditional adjustment for gender and EF (RR 1.53 [1.10 to
.09], p  0.01).
ISCUSSION
he present study is the first to evaluate FC quantitatively
y peak VO2 during CPET simultaneously with quantifica-
ion of MR, LA and LV remodeling, LV systolic and
iastolic function, and ventilatory efficiency with exercise in
large series of patients with organic MR and to link FC to
linical outcome. In asymptomatic patients, FC showed a
ide range from supranormal to markedly reduced. Mitral
egurgitation severity (ERO) is modestly linked to FC,
hereas LV diastolic dysfunction (high E/E=), reduced
orward stroke volume and atrial fibrillation independently
nd cumulatively determined FC. Reduced FC is an inde-
endent marker of higher mid-term risk of clinical events or
urgery. Therefore, CPET is an important tool in asymp-
omatic patients with organic MR to uncover FC reduction
nd to assess mechanisms leading to reduced FC, which
redicts independently higher risk of clinical events. These
igure 2. Clinical outcome after cardiopulmonary exercise testing, display-
ng Kaplan-Meier curves according to the achieved functional capacity
lassified as normal (solid line) or reduced (dotted line) based on achieving
bove or below 84% of the expected VO2 for age, gender, and presence of
xcess weight. The end point measured is the incidence of either clinical
vents (death, heart failure, or new atrial arrhythmia) or the indication of
itral surgery. Note the significant excess event rate in patients witheduced functional capacity. The numbers associated with each line
epresent the three-year rate of event for each group.
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Functional Capacity in MR June 20, 2006:2521–7esults support the guidelines suggestion of wider use of
xercise testing, particularly CPET in MR.
unctional capacity in organic MR. The only routine
orm of assessment of functional capacity in MR is based on
ymptoms occurring with exertion, despite the subjective
ature of this assessment (1). However, asymptomatic
atients with severe MR incur notable mortality under
onservative management (2,3,8), raising the concern that
ack of symptoms may underestimate disease severity.
lthough peak VO2 is on average normal in asymptomatic
atients, FC is frequently markedly reduced. Indeed, re-
uced FC is unexpectedly observed in one of every four to
ve asymptomatic patients with organic MR, underscoring
he importance of exercise stress testing in classifying
unctional disability. Cardiopulmonary exercise testing not
nly detects reduced FC but also can help define the
eatures of cardiac limitations, characterized by plateau in
O2 and O2-pulse with maximum exertional effort, con-
rasting with the pattern of reduced FC contributed to by
xtraneous components.
The determinants of FC reduction in MR have remained
nclear with no definite association between peak VO2 and
Vol (6), whereas the link between ERO and reduced FC
s stronger, possibly through its association to LA pressure
18). Nevertheless, the ERO-FC association is weak, sug-
esting that other factors are important contributors to
educed FC. Indeed, FC is affected by LV characteristics,
ut not by LV systolic function, as all end-systolic LV
ndices showed no association to FC. Conversely, diastolic
unction is a major FC determinant (10,11,19), now shown
o also strongly influence FC in organic MR (7). High E/E=
atio marks diastolic dysfunction with higher LV filling
ressures (9,20) independent of MR (21). The impact of
iastolic dysfunction on FC is also supported by univariate
ssociation between peak VO2 and deceleration time, a
arker of LV compliance. An important result of our study
s that the link of reduced FC to diastolic dysfunction is not
elated to lack of LA adaptation, classically considered to
xplain preserved FC (22). Indeed, with reduced FC, LA is
arger, and LA and LV enlargement compensating for MR
rogression (23) are overwhelmed, with diastolic LV filling
lterations resulting in reduced FC. Other determinants of
educed FC are associated with reduced cardiac output, with
ower exercise stroke volume demonstrated by lower peak O2
ulse and lower O2 pulse change with exercise. Reduced
aseline forward stroke volume is associated with lower peak
2 pulse (r  0.50, p  0.0001) and independently predicts
educed FC, probably through inability to sustain large
orward stroke volume due to MR. Atrial fibrillation is
mportant in MR and, through reduced cardiac output, links
o lower FC even in the absence of symptoms. Although
hese individual FC determinants, which exert a cumulative
ffect leading to reduced FC, are linked to MR, they reflect
ot only the degree of MR but also the severity of MR
onsequences.
Ventilatory efficiency with exercise is an emerging con-
ributor to reduced FC in cardiac diseases (24) that has not aeen evaluated in MR. Ventilatory inefficiency could not be
inked to reduced FC in asymptomatic patients, but may
ontribute to FC limitations with advanced disease or heart
ailure (25).
linical implications. Mitral regurgitation has long had a
enign reputation owing to its frequent asymptomatic presen-
ation (2,3,8). However, the reality is more sobering, as even in
symptomatic patients, clinical outcome may be poor (3). It is
nclear whether the risk attached to MR applies to all patients
r whether high-risk and low-risk subsets can be defined to
ndicate surgical correction. The link between reduced FC and
linical outcome is essential in emphasizing the role of CPET
n detecting such high-risk subsets. One in four to five patients
isplays markedly reduced FC unsuspected clinically and re-
ealed only by CPET. In asymptomatic patients with organic
R, the indication of surgery is hotly debated (1). In asymp-
omatic patients, our study shows that FC reduction can be
onsiderable with exercise level that may be only half of that
xpected for age. Markedly reduced FC (peak VO2 84% of
xpected) is associated with a higher rate of events under
edical management and should lead to prompt consideration
f mitral valve surgery. Therefore, our data should lead to
reater use of CPET in MR to detect objective FC limitation
efore patients develop heart failure, which is associated with
oor postoperative outcome (26). Improvement of peak VO2
fter successful surgery remains uncertain (27,28), warranting
uture large prospective studies. Asymptomatic patients with-
ut markedly reduced FC display a notable event rate, and
urther studies are necessary to define risk stratification and
enefit of surgery in these patients.
Cardiopulmonary exercise testing requires interpretation
ithin clinical context of age, gender, and weight (29,30)
nd of extraneous limitations to define whether peak VO2
eaches individually predicted maximum and whether FC
eduction is MR-related. Peak VO2 and exercise duration
how significant correlation, but exercise time is insensitive
n predicting FC (31) and may be less predictive of outcome.
herefore, CPET, if reliably feasible, should be, in our
pinion, the preferred approach to exercise testing in MR.
tudy limitations. Cardiopulmonary exercise testing was
sed to assess FC, but other exercise modalities may be
sed. Exertional changes in ventricular function (6,32) are
f theoretical interest but raise quality control challenges,
nd detection of transient post-exercise MR and LV
hanges is tenuous. Conversely, CPET is standardized and
irectly applicable to clinical practice.
Diastolic function is difficult to analyze, particularly with
R (9,20). However, the E/E= ratio is only weakly associ-
ted with RVol (r 0.25) and shows stronger association to
C than RVol or ERO (Table 1). Univariate association of
eceleration time to FC supports a diastolic dysfunction role
n determining reduced FC in organic MR.
Complete coronary information is desirable, but coronary
ngiography has risks. Overt history of coronary disease,
xertional angina, and exercise stopped by ischemia were
xcluded. In the 43 patients with subsequent coronary
ngiography, silent obstructive coronary disease tended to
b
(
R
l
e
e
h
d
C
t
o
m
fi
p
L
a
F
c
a
p
R
S
c
5
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
2527JACC Vol. 47, No. 12, 2006 Messika-Zeitoun et al.
June 20, 2006:2521–7 Functional Capacity in MRe less frequent with (8%) than without (19%) reduced FC
p  0.35). Thus, ischemia is unlikely to affect our results.
Reduced FC due to submaximal effort is denoted by low
ER, as observed with extraneous component to FC
imitations. Patients were strongly encouraged to exercise to
xhaustion, as demonstrated by high RER. Whether such
ssential effort to reach peak performance explains the
igher VO2 obtained in the present versus limited previous
ata (27,28) will require further collaborative studies.
onclusions. In asymptomatic patients with organic MR,
he FC objectively and quantitatively assessed by CPET, while
n average in the normal range, ranges widely from supranor-
al to markedly reduced. Approximately one of every four to
ve patients displays unexpected markedly reduced FC. Inde-
endent determinants of markedly reduced FC are impaired
V diastolic function, reduced forward stroke volume, and
trial fibrillation, and they exert a cumulative effect. Reduced
C is an independent predictor of subsequent high risk of
linical events and of surgical indication. Therefore, CPET is
n important physiologic and clinical tool for management of
atients with organic MR.
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